CytoDyn Inc. announced the appointment of Seenu Srinivasan, as Executive Director-CMC Regulatory Affairs. Dr. Srinivasan provides CytoDyn with 30 years of experience in pharmaceutical drug development, including extensive CMC development experience in developing APIs (small and large molecules) and drug products (biological and small molecules) from early phase to commercialization, strategy development and execution.